Discovery, biosynthesis, and mechanism of action of the zaragozic acids: potent inhibitors of squalene synthase.

The zaragozic acids (ZAs), a family of fungal metabolites containing a novel 4,6,7-trihydroxy-2,8-dioxobicyclo[3.2.1]octane-3,4,5-tricarboxylic acid core, were discovered independently by two separate groups screening natural product sources to discover inhibitors of squalene synthase. This family of compounds all contain the same core but differ in their 1-alkyl and their 6-acyl side chains. Production of the ZAs is distributed over an extensive taxonomic range of Ascomycotina or their anamorphic states. The zaragozic acids are very potent inhibitors of squalene synthase that inhibit cholesterol synthesis and lower plasma cholesterol levels in primates. They also inhibit fungal ergosterol synthesis and are potent fungicidal compounds. The biosynthesis of the zaragozic acids appears to proceed through alkyl citrate intermediates and new members of the family have been produced through directed biosynthesis. These potent natural product based inhibitors of squalene synthase have potential to be developed either as cholesterol lowering agents and/or as antifungal agents.

[1]  R. Monaghan,et al.  The preparation of zaragozic acid A analogues by directed biosynthesis. , 1994, The Journal of antibiotics.

[2]  B. Dymock,et al.  The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analogues. , 1994, Journal of medicinal chemistry.

[3]  G. Ness,et al.  Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase. , 1994, Archives of biochemistry and biophysics.

[4]  W. A. Scheffers,et al.  Propionate metabolism in Saccharomyces cerevisiae: implications for the metabolon hypothesis. , 1994, Microbiology.

[5]  R. Hale,et al.  Production of additional squalestatin analogues by directed biosynthesis. , 1994, The Journal of antibiotics.

[6]  R. Marquis,et al.  Diesters of zaragozic acid A: Synthesis and biological activity , 1993 .

[7]  K. Hasumi,et al.  Competitive inhibition of squalene synthetase by squalestatin 1. , 1993, The Journal of antibiotics.

[8]  M. S. Singh,et al.  Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo. , 1993, The Journal of biological chemistry.

[9]  O. Hensens,et al.  The zaragozic acids : structure elucidation of a new class of squalene synthase inhibitors , 1993 .

[10]  K. Wilson,et al.  Zaragozic acid A, a potent inhibitor of squalene synthase: initial chemistry and absolute stereochemistry , 1992 .

[11]  R. Tait.  Development of a radiometric spot-wash assay for squalene synthase. , 1992, Analytical biochemistry.

[12]  A. D. Buss,et al.  The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity. , 1992, The Journal of antibiotics.

[13]  A. Alberts,et al.  The inhibition of cytoplasmic acetoacetyl-CoA thiolase by a triyne carbonate (L-660, 631). , 1989, Biochemical and biophysical research communications.

[14]  R Monaghan,et al.  Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. R. Blohm,et al.  Effects of MER-29, a cholesterol synthesis inhibitor, on mammalian tissue lipides. , 1959, Archives of biochemistry and biophysics.

[16]  A. Borman,et al.  New Inhibitors of in vitro Conversion of Acetate and Mevalonate to Cholesterol , 1959, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[17]  G. Bills,et al.  Selective isolation of fungi from dung of Odocoileus hemionus (mule deer) , 1993 .

[18]  J. Porter,et al.  [26] Enzymatic synthesis of phytoene , 1985 .